Invention Application
- Patent Title: CD137 BINDING FIBRONECTIN TYPE III DOMAINS
-
Application No.: US17732420Application Date: 2022-04-28
-
Publication No.: US20220259289A1Publication Date: 2022-08-18
- Inventor: Michael Diem , Rebecca Hawkins , Steven Jacobs , Manuel Sepulveda
- Applicant: JANSSEN BIOTECH, INC
- Applicant Address: US PA Horsham
- Assignee: JANSSEN BIOTECH, INC
- Current Assignee: JANSSEN BIOTECH, INC
- Current Assignee Address: US PA Horsham
- Main IPC: C07K14/78
- IPC: C07K14/78 ; A61P35/00 ; C12N15/85 ; C07K14/705 ; G01N33/68 ; G01N33/574 ; G01N33/53
Abstract:
FN3 domains that specifically bind to CD137, their conjugates, isolated nucleotides encoding the molecules, vectors, host cells, and methods of making and using them are useful in therapeutic and diagnostic applications.
Public/Granted literature
- US12258385B2 CD137 binding fibronectin type III domains Public/Granted day:2025-03-25
Information query
